210 related articles for article (PubMed ID: 11379329)
1. Relationship between the fecal occult blood test and benign anal disorders.
Sasaki K; Kunimoto M; Hirata K
Hepatogastroenterology; 2001; 48(38):445-7. PubMed ID: 11379329
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
[TBL] [Abstract][Full Text] [Related]
3. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
4. Digital rectal fecal occult blood screening during gynecologic examination.
Willis FL; Fanning J
Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
[TBL] [Abstract][Full Text] [Related]
5. Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test.
Nakama H; Fattah AS; Zhang B; Kamijo N; Uehara Y
Hepatogastroenterology; 2000; 47(35):1277-9. PubMed ID: 11100332
[TBL] [Abstract][Full Text] [Related]
6. Digital fecal occult blood testing in the ambulatory urology clinic.
Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
[TBL] [Abstract][Full Text] [Related]
7. [Complaints in the anal area. Risk a glance at the taboo zone!].
Stiefelhagen P
MMW Fortschr Med; 2002 Feb; 144(9):14-5. PubMed ID: 11921645
[No Abstract] [Full Text] [Related]
8. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
9. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N
Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332
[TBL] [Abstract][Full Text] [Related]
10. Anal cancer masked by benign lesions.
Matteucci P; Pittamiglio H; López-Susviela J
Int Surg; 1983; 68(2):183-4. PubMed ID: 6885303
[TBL] [Abstract][Full Text] [Related]
11. Lower specificity of occult-blood test on stool collected by digital rectal examination.
Zhang B; Nakama H; Fattah AS; Kamijo N
Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
[TBL] [Abstract][Full Text] [Related]
12. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
13. Haemorrhoids, fissures and anal fistulae.
Farquharson M
Trop Doct; 2002 Oct; 32(4):196-201. PubMed ID: 12405296
[No Abstract] [Full Text] [Related]
14. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.
Kahi CJ; Imperiale TF
Am J Med; 2004 Dec; 117(11):837-41. PubMed ID: 15589487
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of clinician accuracy in the diagnosis of benign anal pathology: comparison across specialties and years of experience.
Grucela A; Salinas H; Khaitov S; Steinhagen RM; Gorfine SR; Chessin DB
Dis Colon Rectum; 2010 Jan; 53(1):47-52. PubMed ID: 20010350
[TBL] [Abstract][Full Text] [Related]
19. Common anorectal conditions: Part II. Lesions.
Pfenninger JL; Zainea GG
Am Fam Physician; 2001 Jul; 64(1):77-88. PubMed ID: 11456437
[TBL] [Abstract][Full Text] [Related]
20. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
